Get started
UNITEDTHERAPDRNUNITEDTHERAPDRNUNITEDTHERAPDRN

UNITEDTHERAPDRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

U2TH34 chart


Full chart

Key stats


Market capitalization
‪71.71 B‬ BRL
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
13,088.571
Basic EPS (TTM)
0.008 BRL
Net income (FY)
‪6.44 B‬ BRL
Revenue (FY)
‪15.51 B‬ BRL
Shares float
—
Beta (1Y)
0.08

About United Therapeutics Corporation


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Martine A. Rothblatt
Website
unither.com
Headquarters
Silver Spring
Founded
1996
ISIN
BRU2THBDR002
FIGI
BBG01HH22HD4
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

U2TH34 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where U2TH34 is featured.

See all sparks 


Check out other big names from the same industry as U2TH34.